Tue. 14 May 2024, 4:01pm ET
Benzinga
Earnings, Earnings Beats, News
Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(0.74) by 1.35 percent. This is a 67.56 percent increase over losses of $(2.25) per share from the same period last year.